| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Axons | 91 | 2026 | 386 | 18.030 |
Why?
|
| Ranvier's Nodes | 54 | 2025 | 73 | 10.220 |
Why?
|
| Ankyrins | 38 | 2024 | 96 | 9.250 |
Why?
|
| Spectrin | 35 | 2024 | 70 | 8.360 |
Why?
|
| Axon Initial Segment | 14 | 2025 | 28 | 7.080 |
Why?
|
| Cytoskeleton | 25 | 2022 | 166 | 5.070 |
Why?
|
| Myelin Sheath | 32 | 2024 | 125 | 4.030 |
Why?
|
| Sodium Channels | 27 | 2024 | 98 | 3.960 |
Why?
|
| Neuroglia | 19 | 2025 | 223 | 3.940 |
Why?
|
| Neurons | 38 | 2025 | 2012 | 3.520 |
Why?
|
| Nerve Fibers, Myelinated | 18 | 2020 | 83 | 3.090 |
Why?
|
| Cell Polarity | 10 | 2018 | 119 | 2.520 |
Why?
|
| Ion Channels | 16 | 2022 | 198 | 2.460 |
Why?
|
| Neuromuscular Junction | 3 | 2026 | 94 | 2.370 |
Why?
|
| Oligodendroglia | 14 | 2024 | 86 | 2.350 |
Why?
|
| Membrane Proteins | 17 | 2025 | 1597 | 2.320 |
Why?
|
| Potassium Channels | 12 | 2021 | 154 | 2.280 |
Why?
|
| Animals | 131 | 2026 | 33855 | 2.110 |
Why?
|
| Mice, Knockout | 29 | 2026 | 3834 | 2.100 |
Why?
|
| Action Potentials | 29 | 2025 | 470 | 2.030 |
Why?
|
| Cell Adhesion Molecules | 16 | 2020 | 224 | 1.920 |
Why?
|
| Nerve Tissue Proteins | 22 | 2026 | 1086 | 1.740 |
Why?
|
| Mice | 81 | 2026 | 18238 | 1.740 |
Why?
|
| Carrier Proteins | 6 | 2025 | 1002 | 1.440 |
Why?
|
| Synapses | 9 | 2025 | 444 | 1.420 |
Why?
|
| Protein Transport | 9 | 2020 | 370 | 1.410 |
Why?
|
| Rats | 38 | 2025 | 3380 | 1.390 |
Why?
|
| Microtubules | 4 | 2024 | 130 | 1.350 |
Why?
|
| Shaker Superfamily of Potassium Channels | 5 | 2025 | 31 | 1.350 |
Why?
|
| Nervous System Diseases | 6 | 2021 | 394 | 1.310 |
Why?
|
| Optic Nerve | 13 | 2009 | 112 | 1.290 |
Why?
|
| Cell Membrane | 8 | 2021 | 450 | 1.260 |
Why?
|
| Muscle, Skeletal | 3 | 2026 | 1000 | 1.180 |
Why?
|
| Microfilament Proteins | 5 | 2020 | 271 | 1.170 |
Why?
|
| Proteomics | 4 | 2026 | 616 | 1.030 |
Why?
|
| Actins | 4 | 2021 | 315 | 0.980 |
Why?
|
| Rats, Sprague-Dawley | 19 | 2020 | 1106 | 0.970 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 13 | 2020 | 82 | 0.960 |
Why?
|
| Schwann Cells | 7 | 2020 | 54 | 0.950 |
Why?
|
| Nerve Growth Factors | 7 | 2020 | 67 | 0.930 |
Why?
|
| Central Nervous System | 12 | 2015 | 276 | 0.930 |
Why?
|
| PDZ Domains | 1 | 2025 | 10 | 0.910 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2026 | 70 | 0.910 |
Why?
|
| Nerve Regeneration | 5 | 2023 | 64 | 0.900 |
Why?
|
| Neural Conduction | 8 | 2020 | 82 | 0.900 |
Why?
|
| Cells, Cultured | 19 | 2025 | 2903 | 0.900 |
Why?
|
| Mice, Inbred C57BL | 23 | 2025 | 4714 | 0.840 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2024 | 37 | 0.840 |
Why?
|
| Potassium Channels, Voltage-Gated | 5 | 2004 | 63 | 0.840 |
Why?
|
| Demyelinating Diseases | 6 | 2020 | 69 | 0.830 |
Why?
|
| Neurogenesis | 3 | 2021 | 217 | 0.830 |
Why?
|
| Biological Phenomena | 1 | 2023 | 3 | 0.820 |
Why?
|
| Voltage-Gated Sodium Channels | 2 | 2020 | 13 | 0.800 |
Why?
|
| Gene Editing | 1 | 2025 | 235 | 0.750 |
Why?
|
| Cytoskeletal Proteins | 4 | 2020 | 266 | 0.740 |
Why?
|
| Purkinje Cells | 2 | 2021 | 165 | 0.720 |
Why?
|
| Shaw Potassium Channels | 1 | 2021 | 5 | 0.720 |
Why?
|
| Dynorphins | 1 | 2021 | 10 | 0.720 |
Why?
|
| Oligodendrocyte Precursor Cells | 1 | 2021 | 6 | 0.710 |
Why?
|
| Extracellular Matrix | 7 | 2015 | 235 | 0.710 |
Why?
|
| Hippocampus | 8 | 2020 | 787 | 0.690 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2021 | 26 | 0.660 |
Why?
|
| Nucleoside-Phosphate Kinase | 2 | 2015 | 7 | 0.660 |
Why?
|
| Dyneins | 1 | 2020 | 15 | 0.630 |
Why?
|
| Interneurons | 1 | 2021 | 144 | 0.620 |
Why?
|
| Proteome | 3 | 2023 | 289 | 0.620 |
Why?
|
| Sensory Receptor Cells | 2 | 2023 | 60 | 0.620 |
Why?
|
| Brain | 12 | 2024 | 3165 | 0.600 |
Why?
|
| Endocytosis | 1 | 2020 | 125 | 0.600 |
Why?
|
| Membrane Glycoproteins | 1 | 2021 | 410 | 0.590 |
Why?
|
| Disease Models, Animal | 16 | 2026 | 4669 | 0.570 |
Why?
|
| Blast Injuries | 3 | 2013 | 60 | 0.560 |
Why?
|
| Sodium | 1 | 2019 | 278 | 0.540 |
Why?
|
| Spinal Cord | 4 | 2024 | 259 | 0.520 |
Why?
|
| Membrane Microdomains | 3 | 2009 | 60 | 0.520 |
Why?
|
| Antibodies | 2 | 2023 | 320 | 0.510 |
Why?
|
| Humans | 51 | 2026 | 130496 | 0.500 |
Why?
|
| Microtubule-Associated Proteins | 4 | 2024 | 253 | 0.480 |
Why?
|
| Mice, Transgenic | 11 | 2024 | 2336 | 0.480 |
Why?
|
| Gene Expression Regulation | 6 | 2021 | 2345 | 0.480 |
Why?
|
| Plaque, Amyloid | 1 | 2016 | 66 | 0.470 |
Why?
|
| Calmodulin-Binding Proteins | 2 | 2013 | 66 | 0.460 |
Why?
|
| Guanylate Kinases | 4 | 2010 | 18 | 0.450 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 717 | 0.450 |
Why?
|
| Microscopy, Electron, Transmission | 9 | 2016 | 131 | 0.450 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2010 | 585 | 0.450 |
Why?
|
| Optic Nerve Diseases | 1 | 2016 | 79 | 0.450 |
Why?
|
| Neuronal Plasticity | 5 | 2021 | 293 | 0.440 |
Why?
|
| Green Fluorescent Proteins | 6 | 2016 | 366 | 0.420 |
Why?
|
| Peripheral Nerves | 4 | 2011 | 88 | 0.420 |
Why?
|
| Axonal Transport | 2 | 2011 | 26 | 0.420 |
Why?
|
| Nonlinear Dynamics | 1 | 2014 | 54 | 0.420 |
Why?
|
| Biotinylation | 3 | 2023 | 20 | 0.410 |
Why?
|
| Male | 30 | 2026 | 64498 | 0.410 |
Why?
|
| Peripheral Nervous System | 6 | 2020 | 45 | 0.410 |
Why?
|
| Gangliosides | 2 | 2011 | 71 | 0.400 |
Why?
|
| Evolution, Molecular | 2 | 2024 | 652 | 0.400 |
Why?
|
| Voltage-Gated Sodium Channel beta-4 Subunit | 1 | 2013 | 2 | 0.400 |
Why?
|
| Microglia | 1 | 2015 | 143 | 0.390 |
Why?
|
| Nervous System | 2 | 2011 | 119 | 0.390 |
Why?
|
| Dendrites | 3 | 2016 | 185 | 0.380 |
Why?
|
| Motor Neurons | 2 | 2024 | 137 | 0.380 |
Why?
|
| Aging | 7 | 2024 | 1244 | 0.380 |
Why?
|
| Gap Junctions | 2 | 2016 | 41 | 0.360 |
Why?
|
| Polyneuropathies | 1 | 2011 | 31 | 0.350 |
Why?
|
| Myelin-Associated Glycoprotein | 2 | 2010 | 6 | 0.340 |
Why?
|
| Protein Binding | 5 | 2025 | 1660 | 0.340 |
Why?
|
| Memory Disorders | 1 | 2013 | 203 | 0.340 |
Why?
|
| Ganglia, Spinal | 6 | 2023 | 65 | 0.330 |
Why?
|
| Behavior, Animal | 3 | 2024 | 488 | 0.320 |
Why?
|
| Female | 28 | 2024 | 70401 | 0.320 |
Why?
|
| Brain Concussion | 1 | 2013 | 248 | 0.320 |
Why?
|
| Neurochemistry | 1 | 2009 | 5 | 0.310 |
Why?
|
| Electrical Synapses | 1 | 2010 | 15 | 0.310 |
Why?
|
| ADAM Proteins | 1 | 2010 | 79 | 0.300 |
Why?
|
| Neural Cell Adhesion Molecules | 2 | 2026 | 18 | 0.300 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2009 | 43 | 0.300 |
Why?
|
| Neurosciences | 1 | 2009 | 51 | 0.300 |
Why?
|
| Cell Communication | 3 | 2005 | 188 | 0.290 |
Why?
|
| 2',3'-Cyclic-Nucleotide Phosphodiesterases | 2 | 2006 | 3 | 0.290 |
Why?
|
| tau Proteins | 1 | 2011 | 257 | 0.290 |
Why?
|
| Semaphorins | 2 | 2026 | 34 | 0.290 |
Why?
|
| Mice, Neurologic Mutants | 7 | 2009 | 74 | 0.280 |
Why?
|
| Immunohistochemistry | 10 | 2015 | 1601 | 0.280 |
Why?
|
| Alzheimer Disease | 1 | 2016 | 879 | 0.280 |
Why?
|
| Protein Isoforms | 5 | 2010 | 419 | 0.270 |
Why?
|
| Pain | 2 | 2019 | 429 | 0.270 |
Why?
|
| Models, Biological | 5 | 2022 | 1386 | 0.260 |
Why?
|
| Statistics, Nonparametric | 3 | 2016 | 425 | 0.260 |
Why?
|
| Retinal Ganglion Cells | 3 | 2009 | 115 | 0.260 |
Why?
|
| RNA, Small Interfering | 4 | 2020 | 666 | 0.250 |
Why?
|
| Models, Neurological | 4 | 2014 | 211 | 0.250 |
Why?
|
| RNA-Binding Proteins | 2 | 2021 | 539 | 0.250 |
Why?
|
| Iron-Binding Proteins | 2 | 2016 | 25 | 0.250 |
Why?
|
| Mice, Inbred mdx | 1 | 2026 | 47 | 0.240 |
Why?
|
| Sphingolipids | 2 | 2016 | 36 | 0.240 |
Why?
|
| Mossy Fibers, Hippocampal | 1 | 2026 | 9 | 0.240 |
Why?
|
| Multiprotein Complexes | 2 | 2022 | 196 | 0.240 |
Why?
|
| Receptors, Cell Surface | 2 | 2026 | 420 | 0.240 |
Why?
|
| Sciatic Nerve | 5 | 2011 | 57 | 0.230 |
Why?
|
| Protein Phosphatase 2 | 1 | 2025 | 34 | 0.230 |
Why?
|
| COS Cells | 5 | 2018 | 254 | 0.220 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2025 | 34 | 0.220 |
Why?
|
| Transcription Factors | 3 | 2024 | 2435 | 0.220 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2013 | 413 | 0.220 |
Why?
|
| Autoantibodies | 4 | 2022 | 439 | 0.220 |
Why?
|
| Disks Large Homolog 4 Protein | 4 | 2010 | 15 | 0.220 |
Why?
|
| HEK293 Cells | 2 | 2025 | 804 | 0.220 |
Why?
|
| Immunoblotting | 3 | 2015 | 291 | 0.220 |
Why?
|
| Embryo, Mammalian | 3 | 2013 | 403 | 0.210 |
Why?
|
| Transfection | 3 | 2013 | 961 | 0.210 |
Why?
|
| NAV1.6 Voltage-Gated Sodium Channel | 4 | 2016 | 26 | 0.210 |
Why?
|
| Amino Acid Motifs | 1 | 2024 | 192 | 0.210 |
Why?
|
| Cerebral Cortex | 3 | 2015 | 446 | 0.210 |
Why?
|
| Myelin Proteins | 3 | 2010 | 79 | 0.210 |
Why?
|
| Actin Cytoskeleton | 1 | 2024 | 51 | 0.210 |
Why?
|
| Contactin 1 | 1 | 2023 | 4 | 0.210 |
Why?
|
| Dependovirus | 1 | 2025 | 161 | 0.210 |
Why?
|
| Mental Disorders | 1 | 2011 | 899 | 0.200 |
Why?
|
| Kv1.2 Potassium Channel | 5 | 2025 | 18 | 0.200 |
Why?
|
| Animals, Newborn | 8 | 2021 | 1015 | 0.200 |
Why?
|
| Signal Transduction | 7 | 2016 | 4678 | 0.200 |
Why?
|
| Iron | 2 | 2016 | 305 | 0.200 |
Why?
|
| Mutation | 11 | 2022 | 6117 | 0.200 |
Why?
|
| RNA Interference | 3 | 2011 | 494 | 0.200 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2019 | 484 | 0.190 |
Why?
|
| Muscular Diseases | 1 | 2024 | 124 | 0.190 |
Why?
|
| Sex Characteristics | 1 | 2024 | 323 | 0.190 |
Why?
|
| Myocytes, Cardiac | 3 | 2019 | 677 | 0.190 |
Why?
|
| Receptors, GABA-A | 1 | 2023 | 60 | 0.190 |
Why?
|
| Analysis of Variance | 3 | 2016 | 938 | 0.190 |
Why?
|
| Paraneoplastic Polyneuropathy | 1 | 2022 | 1 | 0.190 |
Why?
|
| Cell Lineage | 1 | 2024 | 343 | 0.180 |
Why?
|
| Cell Differentiation | 5 | 2024 | 1928 | 0.180 |
Why?
|
| CRISPR-Cas Systems | 1 | 2025 | 318 | 0.180 |
Why?
|
| Angelman Syndrome | 2 | 2013 | 67 | 0.180 |
Why?
|
| Astrocytes | 1 | 2024 | 278 | 0.180 |
Why?
|
| Neurons, Afferent | 1 | 2001 | 40 | 0.180 |
Why?
|
| Bipolar Disorder | 1 | 2024 | 346 | 0.170 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2021 | 7 | 0.170 |
Why?
|
| Homeodomain Proteins | 1 | 2024 | 568 | 0.170 |
Why?
|
| Nuclear Envelope | 1 | 2021 | 20 | 0.170 |
Why?
|
| Biosynthetic Pathways | 1 | 2021 | 32 | 0.170 |
Why?
|
| Nuclear Pore | 1 | 2021 | 18 | 0.170 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2023 | 248 | 0.170 |
Why?
|
| Time Factors | 5 | 2016 | 6206 | 0.160 |
Why?
|
| Rotarod Performance Test | 1 | 2020 | 14 | 0.160 |
Why?
|
| PPAR-beta | 1 | 2020 | 4 | 0.160 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2021 | 165 | 0.160 |
Why?
|
| Tolloid-Like Metalloproteinases | 1 | 2020 | 2 | 0.160 |
Why?
|
| Bone Morphogenetic Protein 1 | 1 | 2020 | 2 | 0.160 |
Why?
|
| Cell Survival | 2 | 2021 | 836 | 0.160 |
Why?
|
| Computer Simulation | 2 | 2014 | 673 | 0.160 |
Why?
|
| Fatigue | 1 | 2021 | 193 | 0.160 |
Why?
|
| Cluster Analysis | 1 | 2021 | 412 | 0.160 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2021 | 152 | 0.160 |
Why?
|
| Mice, 129 Strain | 1 | 2020 | 97 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 4 | 2008 | 716 | 0.160 |
Why?
|
| Somatosensory Cortex | 1 | 2020 | 54 | 0.160 |
Why?
|
| Mass Spectrometry | 2 | 2020 | 357 | 0.150 |
Why?
|
| Mitochondria | 1 | 2025 | 775 | 0.150 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2020 | 91 | 0.150 |
Why?
|
| Friedreich Ataxia | 2 | 2016 | 30 | 0.150 |
Why?
|
| Pyramidal Cells | 2 | 2011 | 151 | 0.150 |
Why?
|
| Nociceptors | 1 | 2019 | 14 | 0.150 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2004 | 974 | 0.150 |
Why?
|
| Molecular Sequence Data | 5 | 2015 | 3487 | 0.150 |
Why?
|
| Protein Domains | 1 | 2020 | 252 | 0.150 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2022 | 284 | 0.150 |
Why?
|
| Rabbits | 4 | 2011 | 573 | 0.140 |
Why?
|
| Contactin 2 | 3 | 2008 | 4 | 0.140 |
Why?
|
| Amino Acid Sequence | 4 | 2015 | 2406 | 0.140 |
Why?
|
| Motor Activity | 2 | 2020 | 494 | 0.140 |
Why?
|
| Motor Neuron Disease | 1 | 2018 | 16 | 0.140 |
Why?
|
| Brain Injuries | 2 | 2015 | 703 | 0.140 |
Why?
|
| Cholesterol | 1 | 2021 | 538 | 0.140 |
Why?
|
| Age Factors | 3 | 2016 | 2839 | 0.130 |
Why?
|
| Macaca mulatta | 3 | 2015 | 481 | 0.130 |
Why?
|
| Muscle Hypotonia | 1 | 2018 | 194 | 0.130 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 368 | 0.130 |
Why?
|
| Blotting, Western | 3 | 2010 | 1017 | 0.130 |
Why?
|
| MEF2 Transcription Factors | 1 | 2016 | 34 | 0.130 |
Why?
|
| Diffusion | 1 | 2016 | 57 | 0.120 |
Why?
|
| Cholera Toxin | 1 | 2016 | 44 | 0.120 |
Why?
|
| RNA, Messenger | 1 | 2022 | 2560 | 0.120 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2016 | 14 | 0.120 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 1 | 2016 | 18 | 0.120 |
Why?
|
| Zebrafish | 2 | 2011 | 419 | 0.120 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 2016 | 14 | 0.120 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2016 | 16 | 0.120 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2016 | 13 | 0.120 |
Why?
|
| Mice, Mutant Strains | 2 | 2015 | 358 | 0.120 |
Why?
|
| Membrane Potentials | 3 | 2012 | 292 | 0.120 |
Why?
|
| Heart Failure | 3 | 2019 | 2335 | 0.120 |
Why?
|
| Ischemia | 1 | 2019 | 358 | 0.120 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2022 | 624 | 0.110 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2016 | 115 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 2 | 2023 | 324 | 0.110 |
Why?
|
| Myelin Basic Protein | 2 | 2013 | 67 | 0.110 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2015 | 22 | 0.110 |
Why?
|
| Kv1.1 Potassium Channel | 3 | 2001 | 39 | 0.110 |
Why?
|
| Nerve Net | 3 | 2014 | 256 | 0.110 |
Why?
|
| Receptors, Chemokine | 1 | 2015 | 47 | 0.110 |
Why?
|
| Serotonin | 1 | 2016 | 210 | 0.110 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 191 | 0.110 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2016 | 248 | 0.110 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2015 | 73 | 0.110 |
Why?
|
| Seizures | 1 | 2020 | 874 | 0.110 |
Why?
|
| Subcellular Fractions | 3 | 2004 | 90 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 1210 | 0.110 |
Why?
|
| Anxiety | 1 | 2021 | 1007 | 0.110 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2015 | 72 | 0.110 |
Why?
|
| Calpain | 2 | 2016 | 43 | 0.110 |
Why?
|
| Mechanoreceptors | 1 | 2014 | 12 | 0.100 |
Why?
|
| Microscopy, Electron | 3 | 2010 | 309 | 0.100 |
Why?
|
| Cytological Techniques | 1 | 2014 | 18 | 0.100 |
Why?
|
| Rats, Inbred Lew | 4 | 2012 | 52 | 0.100 |
Why?
|
| Wnt Proteins | 1 | 2015 | 192 | 0.100 |
Why?
|
| Electron Microscope Tomography | 1 | 2014 | 24 | 0.100 |
Why?
|
| Multiple Sclerosis | 3 | 2020 | 393 | 0.100 |
Why?
|
| Neurites | 1 | 2014 | 44 | 0.100 |
Why?
|
| Touch | 1 | 2014 | 38 | 0.100 |
Why?
|
| Electrophysiology | 4 | 2008 | 249 | 0.100 |
Why?
|
| Wnt Signaling Pathway | 1 | 2015 | 208 | 0.100 |
Why?
|
| Cysteine | 2 | 2013 | 137 | 0.100 |
Why?
|
| Ear | 1 | 2013 | 26 | 0.100 |
Why?
|
| Voltage-Gated Sodium Channel beta Subunits | 1 | 2013 | 2 | 0.100 |
Why?
|
| Synaptic Transmission | 1 | 2015 | 314 | 0.100 |
Why?
|
| NAV1.1 Voltage-Gated Sodium Channel | 1 | 2013 | 15 | 0.100 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2013 | 64 | 0.100 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2014 | 76 | 0.100 |
Why?
|
| Neuritis, Autoimmune, Experimental | 1 | 2012 | 1 | 0.100 |
Why?
|
| Hearing Loss | 2 | 2013 | 204 | 0.100 |
Why?
|
| Vertebrates | 1 | 2013 | 36 | 0.100 |
Why?
|
| Optical Imaging | 1 | 2013 | 76 | 0.090 |
Why?
|
| Motor Cortex | 1 | 2012 | 57 | 0.090 |
Why?
|
| I-kappa B Proteins | 1 | 2012 | 36 | 0.090 |
Why?
|
| Protein Subunits | 2 | 2013 | 159 | 0.090 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2011 | 12 | 0.090 |
Why?
|
| Gangliosidosis, GM1 | 1 | 2011 | 7 | 0.090 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 1964 | 0.090 |
Why?
|
| Complement C3 | 1 | 2011 | 43 | 0.090 |
Why?
|
| Injections, Subcutaneous | 1 | 2011 | 134 | 0.090 |
Why?
|
| Biological Evolution | 1 | 2013 | 222 | 0.090 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2012 | 132 | 0.090 |
Why?
|
| Heart Ventricles | 1 | 2016 | 762 | 0.090 |
Why?
|
| Intellectual Disability | 1 | 2018 | 1080 | 0.080 |
Why?
|
| Coculture Techniques | 2 | 2012 | 231 | 0.080 |
Why?
|
| Versicans | 1 | 2010 | 15 | 0.080 |
Why?
|
| Skin | 1 | 2014 | 540 | 0.080 |
Why?
|
| Antibodies, Blocking | 1 | 2010 | 47 | 0.080 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2010 | 35 | 0.080 |
Why?
|
| G(M1) Ganglioside | 2 | 2007 | 10 | 0.080 |
Why?
|
| Mice, Inbred ICR | 1 | 2010 | 137 | 0.080 |
Why?
|
| Phenotype | 4 | 2021 | 4479 | 0.080 |
Why?
|
| Antibody Specificity | 1 | 2010 | 164 | 0.080 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 89 | 0.080 |
Why?
|
| Silver Staining | 1 | 2010 | 5 | 0.080 |
Why?
|
| Drosophila Proteins | 1 | 2016 | 788 | 0.080 |
Why?
|
| Brain Ischemia | 1 | 2012 | 268 | 0.080 |
Why?
|
| GPI-Linked Proteins | 1 | 2010 | 108 | 0.080 |
Why?
|
| Cross Reactions | 1 | 2010 | 159 | 0.080 |
Why?
|
| Septins | 1 | 2009 | 2 | 0.080 |
Why?
|
| Ion Channel Gating | 1 | 2010 | 120 | 0.080 |
Why?
|
| Zebrafish Proteins | 1 | 2011 | 132 | 0.080 |
Why?
|
| Phosphorylation | 3 | 2025 | 1579 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 382 | 0.080 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2009 | 34 | 0.080 |
Why?
|
| Education, Graduate | 1 | 2009 | 21 | 0.080 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2010 | 139 | 0.080 |
Why?
|
| International Educational Exchange | 1 | 2009 | 16 | 0.080 |
Why?
|
| Homeostasis | 1 | 2014 | 715 | 0.080 |
Why?
|
| Peer Review, Research | 1 | 2009 | 46 | 0.080 |
Why?
|
| Mice, Inbred C3H | 2 | 1999 | 97 | 0.080 |
Why?
|
| Postural Balance | 1 | 2010 | 134 | 0.070 |
Why?
|
| GTP-Binding Proteins | 1 | 2009 | 160 | 0.070 |
Why?
|
| CASP8 and FADD-Like Apoptosis Regulating Protein | 2 | 2007 | 3 | 0.070 |
Why?
|
| Casein Kinase II | 1 | 2008 | 12 | 0.070 |
Why?
|
| Cell Death | 1 | 2009 | 233 | 0.070 |
Why?
|
| Cochlear Nerve | 2 | 2005 | 8 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2009 | 256 | 0.070 |
Why?
|
| Acute Disease | 1 | 2011 | 1149 | 0.070 |
Why?
|
| Atrial Fibrillation | 1 | 2016 | 734 | 0.070 |
Why?
|
| Adenoviridae | 2 | 2008 | 583 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2009 | 360 | 0.070 |
Why?
|
| Neuroprotective Agents | 1 | 2009 | 162 | 0.070 |
Why?
|
| Mentors | 1 | 2009 | 168 | 0.070 |
Why?
|
| Presynaptic Terminals | 1 | 2008 | 79 | 0.070 |
Why?
|
| Adult Stem Cells | 1 | 2008 | 49 | 0.070 |
Why?
|
| Hypoxia | 1 | 2009 | 245 | 0.070 |
Why?
|
| Brevican | 1 | 2007 | 2 | 0.070 |
Why?
|
| Corpus Callosum | 1 | 2008 | 106 | 0.070 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2007 | 31 | 0.070 |
Why?
|
| Polyradiculoneuropathy | 1 | 2007 | 5 | 0.070 |
Why?
|
| Prefrontal Cortex | 1 | 2009 | 192 | 0.070 |
Why?
|
| RNA | 2 | 2007 | 515 | 0.060 |
Why?
|
| Lectins, C-Type | 1 | 2007 | 69 | 0.060 |
Why?
|
| Complement System Proteins | 1 | 2007 | 59 | 0.060 |
Why?
|
| Brain Chemistry | 2 | 2004 | 112 | 0.060 |
Why?
|
| Base Sequence | 1 | 2011 | 2750 | 0.060 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2006 | 47 | 0.060 |
Why?
|
| Hyperkinesis | 1 | 2006 | 27 | 0.060 |
Why?
|
| Wiskott-Aldrich Syndrome Protein Family | 1 | 2006 | 8 | 0.060 |
Why?
|
| Stem Cell Transplantation | 1 | 2008 | 231 | 0.060 |
Why?
|
| Rats, Wistar | 1 | 2007 | 301 | 0.060 |
Why?
|
| Macromolecular Substances | 2 | 2003 | 129 | 0.060 |
Why?
|
| Heart | 1 | 2010 | 661 | 0.060 |
Why?
|
| Wallerian Degeneration | 1 | 2005 | 10 | 0.060 |
Why?
|
| Alleles | 2 | 2022 | 1685 | 0.060 |
Why?
|
| Gliosis | 1 | 2005 | 31 | 0.060 |
Why?
|
| Glucose | 1 | 2009 | 853 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 693 | 0.060 |
Why?
|
| Intermediate Filaments | 1 | 2004 | 10 | 0.050 |
Why?
|
| Stroke | 1 | 2012 | 1055 | 0.050 |
Why?
|
| Chronic Disease | 2 | 2012 | 1236 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 488 | 0.050 |
Why?
|
| Detergents | 1 | 2004 | 19 | 0.050 |
Why?
|
| Solubility | 1 | 2004 | 117 | 0.050 |
Why?
|
| N-Acylsphingosine Galactosyltransferase | 1 | 2003 | 1 | 0.050 |
Why?
|
| Galactosyltransferases | 1 | 2003 | 8 | 0.050 |
Why?
|
| Glycosphingolipids | 1 | 2003 | 12 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 613 | 0.050 |
Why?
|
| Neuronal Outgrowth | 1 | 2023 | 5 | 0.050 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2003 | 28 | 0.050 |
Why?
|
| Laminin | 1 | 2003 | 67 | 0.050 |
Why?
|
| Pregnancy | 2 | 2013 | 7408 | 0.050 |
Why?
|
| Paresthesia | 1 | 2022 | 9 | 0.050 |
Why?
|
| Hypesthesia | 1 | 2022 | 10 | 0.050 |
Why?
|
| Patch-Clamp Techniques | 2 | 2016 | 273 | 0.050 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2023 | 175 | 0.040 |
Why?
|
| Methylation | 1 | 2021 | 198 | 0.040 |
Why?
|
| Heterozygote | 1 | 2003 | 722 | 0.040 |
Why?
|
| Remyelination | 1 | 2020 | 8 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2022 | 279 | 0.040 |
Why?
|
| Spiral Ganglion | 2 | 2013 | 10 | 0.040 |
Why?
|
| Peptides | 1 | 2003 | 705 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2023 | 700 | 0.040 |
Why?
|
| Cattle | 1 | 2001 | 502 | 0.040 |
Why?
|
| Delayed Rectifier Potassium Channels | 1 | 1999 | 6 | 0.040 |
Why?
|
| Tenascin | 1 | 1999 | 33 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2023 | 681 | 0.040 |
Why?
|
| Calcium | 2 | 2016 | 1028 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 1999 | 157 | 0.040 |
Why?
|
| Kinetics | 1 | 2020 | 1087 | 0.030 |
Why?
|
| S-Nitrosothiols | 1 | 1998 | 4 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1999 | 808 | 0.030 |
Why?
|
| Tetraethylammonium | 1 | 1998 | 10 | 0.030 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 1998 | 11 | 0.030 |
Why?
|
| 4-Aminopyridine | 1 | 1998 | 28 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 1998 | 80 | 0.030 |
Why?
|
| Epitopes | 1 | 1999 | 321 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2018 | 112 | 0.030 |
Why?
|
| Mitomycin | 1 | 1998 | 40 | 0.030 |
Why?
|
| Histones | 1 | 2021 | 544 | 0.030 |
Why?
|
| Potassium Channel Blockers | 1 | 1998 | 84 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2020 | 374 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 982 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 134 | 0.030 |
Why?
|
| Gerbillinae | 1 | 2016 | 53 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2022 | 1223 | 0.030 |
Why?
|
| Intercellular Junctions | 1 | 2015 | 24 | 0.030 |
Why?
|
| Dogs | 1 | 2016 | 616 | 0.030 |
Why?
|
| Proteolysis | 1 | 2016 | 197 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 2015 | 140 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 1998 | 466 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2017 | 769 | 0.030 |
Why?
|
| Lipids | 1 | 2018 | 561 | 0.030 |
Why?
|
| Merkel Cells | 1 | 2014 | 4 | 0.030 |
Why?
|
| Neuroanatomical Tract-Tracing Techniques | 1 | 2014 | 6 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2016 | 654 | 0.030 |
Why?
|
| Tympanic Membrane | 1 | 2013 | 25 | 0.020 |
Why?
|
| Evoked Potentials | 1 | 2014 | 112 | 0.020 |
Why?
|
| Stroke Volume | 1 | 2016 | 542 | 0.020 |
Why?
|
| Proteoglycans | 1 | 2013 | 79 | 0.020 |
Why?
|
| Cochlea | 1 | 2013 | 87 | 0.020 |
Why?
|
| Explosions | 1 | 2012 | 6 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 339 | 0.020 |
Why?
|
| Regeneration | 1 | 2015 | 227 | 0.020 |
Why?
|
| White Matter | 1 | 2015 | 215 | 0.020 |
Why?
|
| Warfare | 1 | 2012 | 33 | 0.020 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2012 | 32 | 0.020 |
Why?
|
| Iraq War, 2003-2011 | 1 | 2012 | 128 | 0.020 |
Why?
|
| Biomarkers | 1 | 2022 | 3388 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2014 | 259 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2016 | 550 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2012 | 187 | 0.020 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2012 | 137 | 0.020 |
Why?
|
| Drosophila | 1 | 2016 | 785 | 0.020 |
Why?
|
| Molecular Imaging | 1 | 2012 | 60 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2012 | 154 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 371 | 0.020 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2010 | 40 | 0.020 |
Why?
|
| Military Personnel | 1 | 2012 | 210 | 0.020 |
Why?
|
| Photomicrography | 1 | 2009 | 10 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2014 | 956 | 0.020 |
Why?
|
| Hemagglutinins | 1 | 2008 | 24 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2012 | 956 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2016 | 3380 | 0.020 |
Why?
|
| Transplantation Chimera | 1 | 2008 | 46 | 0.020 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2008 | 160 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2012 | 387 | 0.020 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2008 | 49 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2008 | 364 | 0.020 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2007 | 45 | 0.020 |
Why?
|
| Spinal Nerve Roots | 1 | 2007 | 17 | 0.020 |
Why?
|
| Neurofilament Proteins | 1 | 2007 | 36 | 0.020 |
Why?
|
| Autoantigens | 1 | 2007 | 100 | 0.020 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2008 | 152 | 0.020 |
Why?
|
| Nerve Fibers | 1 | 2007 | 69 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2006 | 46 | 0.020 |
Why?
|
| Dopamine Antagonists | 1 | 2006 | 38 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2007 | 155 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2008 | 309 | 0.010 |
Why?
|
| Binding Sites | 1 | 2008 | 1142 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2006 | 440 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2007 | 695 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 2005 | 27 | 0.010 |
Why?
|
| Myocardium | 1 | 2010 | 863 | 0.010 |
Why?
|
| NAV1.2 Voltage-Gated Sodium Channel | 1 | 2005 | 10 | 0.010 |
Why?
|
| Morphogenesis | 1 | 2006 | 186 | 0.010 |
Why?
|
| Fetus | 1 | 2008 | 566 | 0.010 |
Why?
|
| Hair Cells, Auditory | 1 | 2005 | 66 | 0.010 |
Why?
|
| Deafness | 1 | 2005 | 79 | 0.010 |
Why?
|
| Inflammation | 1 | 2012 | 1480 | 0.010 |
Why?
|
| Aged | 2 | 2016 | 20928 | 0.010 |
Why?
|
| Auditory Pathways | 1 | 2004 | 20 | 0.010 |
Why?
|
| Organelles | 1 | 2004 | 20 | 0.010 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2004 | 45 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 2004 | 33 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2004 | 41 | 0.010 |
Why?
|
| Enzymes | 1 | 2004 | 44 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2003 | 54 | 0.010 |
Why?
|
| Paxillin | 1 | 2003 | 13 | 0.010 |
Why?
|
| Galactose | 1 | 2003 | 53 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 254 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 591 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 1610 | 0.010 |
Why?
|
| Middle Aged | 2 | 2016 | 28448 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 308 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 13234 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2003 | 578 | 0.010 |
Why?
|
| Adult | 2 | 2016 | 31183 | 0.010 |
Why?
|
| Models, Animal | 1 | 2004 | 451 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 14946 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 337 | 0.010 |
Why?
|
| Homozygote | 1 | 2003 | 539 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2003 | 454 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 6812 | 0.010 |
Why?
|
| Nitrogen Oxides | 1 | 1998 | 5 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1998 | 33 | 0.010 |
Why?
|
| Nitroso Compounds | 1 | 1998 | 7 | 0.010 |
Why?
|
| Tetrodotoxin | 1 | 1998 | 48 | 0.010 |
Why?
|
| Hydrazines | 1 | 1998 | 28 | 0.010 |
Why?
|
| Sulfhydryl Compounds | 1 | 1998 | 54 | 0.010 |
Why?
|
| Vagus Nerve | 1 | 1998 | 50 | 0.010 |
Why?
|
| Cyclic GMP | 1 | 1998 | 90 | 0.010 |
Why?
|
| Child | 1 | 2018 | 26100 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1998 | 434 | 0.010 |
Why?
|
| Stem Cells | 1 | 1999 | 711 | 0.010 |
Why?
|